KalVista Pharmaceuticals (KALV) Current Assets (2016 - 2024)
Historic Current Assets for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $286.0 million.
- KalVista Pharmaceuticals' Current Assets changed N/A to $286.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $286.0 million, marking a year-over-year change of. This contributed to the annual value of $225.7 million for FY2024, which is N/A changed from last year.
- Latest data reveals that KalVista Pharmaceuticals reported Current Assets of $286.0 million as of Q4 2024.
- Over the past 5 years, KalVista Pharmaceuticals' Current Assets peaked at $286.0 million during Q4 2024, and registered a low of $62.5 million during Q1 2021.
- For the 4-year period, KalVista Pharmaceuticals' Current Assets averaged around $136.7 million, with its median value being $116.4 million (2023).
- Its Current Assets has fluctuated over the past 5 years, first crashed by 3686.78% in 2021, then soared by 2789.07% in 2024.
- Quarter analysis of 4 years shows KalVista Pharmaceuticals' Current Assets stood at $72.1 million in 2020, then decreased by 13.28% to $62.5 million in 2021, then soared by 105.76% to $128.6 million in 2023, then skyrocketed by 122.37% to $286.0 million in 2024.
- Its Current Assets stands at $286.0 million for Q4 2024, versus $152.3 million for Q4 2024 and $191.6 million for Q3 2024.